Vinci Partners and Lazuli Partners completed the investment in Farmax for BRL200m.

Vinci Partners and Lazuli Partners, private equity firms, completed the investment in Farmax, a cosmetics provider, for BRL200m. "Since Vinci arrived, we have been experiencing a two-year growth cycle above what we had planned. And we understood that we needed new funding to accelerate the company's expansion," Ronaldo Ribeiro, Farmax CEO.